Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Neumora Therapeutics Inc (NASDAQ: NMRA) was $0.70 for the day, up 5.38% from the previous closing price of $0.67. In other words, the price has increased by $5.38 from its previous closing price. On the day, 1.18 million shares were traded.
Ratios:
Our analysis of NMRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.98 and its Current Ratio is at 8.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Stifel Downgraded its Buy to Hold on March 07, 2025, whereas the target price for the stock was revised from $6 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 12 ’25 when Henry Gosebruch bought 15,000 shares for $1.43 per share.
BERNS PAUL L sold 13,871 shares of NMRA for $23,468 on Feb 18 ’25. The insider now owns 7,405,004 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Milligan Michael Lee, who serves as the insider of the company, sold 1,978 shares for $1.69 each. As a result, the insider received 3,351 and left with 22,470 shares of the company.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $17.19, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -21.22%, while the 200-Day Moving Average is calculated to be -90.00%.
Shares Statistics:
A total of 161.75M shares are outstanding, with a floating share count of 65.21M. Insiders hold about 60.18% of the company’s shares, while institutions hold 28.39% stake in the company.
